Document Detail


PET/CT imaging: what radiologists need to know.
MedLine Citation:
PMID:  17921089     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Positron emission tomography (PET)/computed tomography (CT) imaging is frequently requested in Oncology. Radiologists and nuclear medicine physicians are often asked to perform a panel of imaging examinations as part of the initial staging or follow-up of cancer patients. Medical imaging must therefore integrate polyvalent skills enabling imaging specialists to understand and interpret all types of images. In this context, PET imaging combined with non-enhanced CT, and diagnostic quality contrast-enhanced CT scan and optimisation of CT settings, is part of this multidisciplinary approach requiring the specific skills of a radiologist and a nuclear medicine physician. This approach must therefore be conducted in both directions: radiologists and nuclear medicine physicians should both know how to correlate PET and CT images, while preserving the specificities of each discipline. Radiologists need to be aware of several aspects of PET imaging: PET technology, the examination procedure and injection of iodinated contrast agent for high quality diagnostic CT, ideally followed by double interpretation of CT images, PET images and fused images. Radiologists should be familiar with PET imaging, as this procedure may be associated with several pitfalls and artefacts that need interpretation by a trained specialist. The authors analyse the examination technique of PET combined with non-enhanced and/or contrast-enhanced CT and the proposals for optimal interpretation of normal or pathological PET/CT fusion images.
Authors:
M Benamor; L Ollivier; H Brisse; G Moulin-Romsee; V Servois; S Neuenschwander
Related Documents :
20196419 - Factors affecting standardized uptake value (suv) of positron emission tomography (pet)...
17724289 - What does fluorodeoxyglucose pet imaging add to a clinical diagnosis of dementia?
22476999 - Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at ...
22154129 - Accuracy of mri in prediction of tumour thickness and nodal stage in oral squamous cell...
19914979 - Phased versus midventilation attenuation-corrected respiration-correlated pet for patie...
16856569 - Pet/ct today: system and its impact on cancer diagnosis.
1563449 - Computed tomography in the assessment of seizure-induced supratentorial neuron loss.
12671819 - The efficacy of urinalysis, plain films, and spiral ct in ed patients with suspected re...
16715019 - Reliability of a new instrument for measuring maximum rising strength.
Publication Detail:
Type:  Journal Article; Review     Date:  2007-10-01
Journal Detail:
Title:  Cancer imaging : the official publication of the International Cancer Imaging Society     Volume:  7 Spec No A     ISSN:  1470-7330     ISO Abbreviation:  Cancer Imaging     Publication Date:  2007  
Date Detail:
Created Date:  2007-10-08     Completed Date:  2007-11-08     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  101172931     Medline TA:  Cancer Imaging     Country:  England    
Other Details:
Languages:  eng     Pagination:  S95-9     Citation Subset:  IM    
Affiliation:
Institut Curie, Departement d'imagerie, 75005 Paris, France. myriam.benamor@curie.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Contrast Media
Fluorodeoxyglucose F18 / diagnostic use
Humans
Image Interpretation, Computer-Assisted
Neoplasms / pathology,  radiography*,  radionuclide imaging*
Positron-Emission Tomography*
Radiopharmaceuticals / diagnostic use
Tomography, X-Ray Computed*
Whole Body Imaging*
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Colorectal cancer: imaging surveillance following resection of primary tumour.
Next Document:  Multimodality imaging of head and neck cancer.